Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 29 Apr 2021
Toothful or toothless? Biden's biosimilar bills under the microscope
28 April 2021 - How much muscle did Congress invest in a pair of bills recently signed by President Biden? ...
Posted by Michael Wonder on 29 Apr 2021
Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration
27 April 2021 - The European Network for Health Technology Assessment (EUnetHTA) was established in 2006 and comprises over eighty organisations ...
Posted by Michael Wonder on 29 Apr 2021
ISPOR launches HEOR solutions centre
27 April 2021 - New resource offers easy access to HEOR expertise from leading companies in the field. ...
Posted by Michael Wonder on 29 Apr 2021
CCRM and Amgen partner to advance emerging medical innovations
29 April 2021 - New fund to support regenerative medicine discoveries with high potential impact for patients. ...
Posted by Michael Wonder on 29 Apr 2021
Bavencio receives reimbursement recommendation from pCODR and INESSS for the maintenance treatment of patients with advanced bladder cancer
29 April 2021 - EMD Serono Canada and Pfizer Canada are pleased to announce that Bavencio (avelumab for injection) has received ...
Posted by Michael Wonder on 29 Apr 2021
Australia accused of delaying campaign to allow generic COVID vaccines
29 April 2021 - Australia is among a group of rich countries accused of standing in the way of some ...
Posted by Michael Wonder on 29 Apr 2021
Biden vows to target high prescription drug prices, strengthen ACA
29 April 2021 - President's wide-ranging speech to Congress included key issues for older Americans. ...
Posted by Michael Wonder on 29 Apr 2021
CMS should offer immediate reimbursement coverage to FDA approved breakthrough devices
29 April 2021 - In 2016 the U.S. Congress passed, and President Barack Obama signed, the 21st Century Cures Act. Section ...
Posted by Michael Wonder on 29 Apr 2021
EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen
29 April 2021 - EMA has started evaluating an application to extend the use of Olumiant (baricitinib) to include treatment ...
Posted by Michael Wonder on 29 Apr 2021
Biogen provides regulatory update on the supplemental biologic license application for subcutaneous administration of Tysabri (natalizumab)
28 April 2021 - Biogen today announced that it has received a complete response letter from the U.S. FDA for ...
Posted by Michael Wonder on 29 Apr 2021
Biden called for drug pricing reform this year. But it’s an empty call.
28 April 2021 - President Biden told Congress Wednesday to let Medicare negotiate drug prices this year. But it’s an ...
Posted by Michael Wonder on 29 Apr 2021
Valeo Pharma’s Redesca and Redesca HP to be covered under the Ontario Public Drug Benefit Program
28 April 2021 - Additional provincial coverage expected to follow. ...
Posted by Michael Wonder on 29 Apr 2021
Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review
26 April 2021 - The objective was to describe the type and level of ethical integration in published health technology assessment ...
Posted by Michael Wonder on 29 Apr 2021
Australia has surpassed 2 million vaccines but lacks data on second doses
28 April 2021 - Australians will not be told how many people have received a second dose of the COVID-19 vaccine ...
Posted by Michael Wonder on 29 Apr 2021
COVID-19 vaccine weekly safety report - 28-04-2021
29 April 2021 - The TGA has been closely monitoring suspected adverse events from the use of COVID-19 vaccines since the ...